医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
36期
169-170
,共2页
血清胱抑素C%肝癌%胃癌%结直肠癌
血清胱抑素C%肝癌%胃癌%結直腸癌
혈청광억소C%간암%위암%결직장암
Serum cystatin%C Liver cancer%Gastric cancer%Colorectal carcinoma
目的：对消化系统恶性肿瘤患者血清胱抑素C(Cys C)检测的临床意义进行初步探讨。方法选择30例消化系统良性肿瘤患者，30例健康体检者和30例肝癌、30例胃癌、30例结直肠癌患者，检测血清中Cys C的水平，并对结果进行比较分析。结果消化系统恶性肿瘤患者血清中Cys C水平较消化系统良性肿瘤患者组和正常对照组显著升高(P<0.01)，消化系统良性肿瘤患者血清Cys C水平与正常对照组无显著差异(P>0.05)。其中，肝癌患者Cys C水平升高幅度最大，异常率最高。结论血清Cys C可作为消化系统恶性肿瘤的辅助诊断指标，具有一定的临床应用价值。
目的：對消化繫統噁性腫瘤患者血清胱抑素C(Cys C)檢測的臨床意義進行初步探討。方法選擇30例消化繫統良性腫瘤患者，30例健康體檢者和30例肝癌、30例胃癌、30例結直腸癌患者，檢測血清中Cys C的水平，併對結果進行比較分析。結果消化繫統噁性腫瘤患者血清中Cys C水平較消化繫統良性腫瘤患者組和正常對照組顯著升高(P<0.01)，消化繫統良性腫瘤患者血清Cys C水平與正常對照組無顯著差異(P>0.05)。其中，肝癌患者Cys C水平升高幅度最大，異常率最高。結論血清Cys C可作為消化繫統噁性腫瘤的輔助診斷指標，具有一定的臨床應用價值。
목적：대소화계통악성종류환자혈청광억소C(Cys C)검측적림상의의진행초보탐토。방법선택30례소화계통량성종류환자，30례건강체검자화30례간암、30례위암、30례결직장암환자，검측혈청중Cys C적수평，병대결과진행비교분석。결과소화계통악성종류환자혈청중Cys C수평교소화계통량성종류환자조화정상대조조현저승고(P<0.01)，소화계통량성종류환자혈청Cys C수평여정상대조조무현저차이(P>0.05)。기중，간암환자Cys C수평승고폭도최대，이상솔최고。결론혈청Cys C가작위소화계통악성종류적보조진단지표，구유일정적림상응용개치。
Objective To study the clinical significance of serum cystatin C(Cys C) in patients with digestive system carcinomas. Methods Serum Cys C was determined in 30 patients with digestive system benign tumors, 30 healthy subjects, 30 patients with liver cancer, 30 patients with gastric cancer and 30 colorectal carcinoma. Results The levels of serum Cys C were significantly higher in patients with malignant tumor than in patients with benign tunmor and controls(P<0.01). There were no significant differences between levels in patients with benign tumor and healthy(P>0.05). The level of cystatin C in patients with liver cancer was higher than other groups. Conclusion Serum Cys C can be used as a parameter to identify digestive system carcinomas.
